+

WO2003039270A1 - Antiobestic foods and drinks - Google Patents

Antiobestic foods and drinks Download PDF

Info

Publication number
WO2003039270A1
WO2003039270A1 PCT/JP2002/011608 JP0211608W WO03039270A1 WO 2003039270 A1 WO2003039270 A1 WO 2003039270A1 JP 0211608 W JP0211608 W JP 0211608W WO 03039270 A1 WO03039270 A1 WO 03039270A1
Authority
WO
WIPO (PCT)
Prior art keywords
antiobestic
foods
drinks
acceptable salts
physiologically acceptable
Prior art date
Application number
PCT/JP2002/011608
Other languages
French (fr)
Japanese (ja)
Inventor
Hisami Shinohara
Gou Shinohara
Noriyasu Kuno
Original Assignee
The Nisshin Oillio,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Nisshin Oillio,Ltd. filed Critical The Nisshin Oillio,Ltd.
Priority to JP2003541376A priority Critical patent/JPWO2003039270A1/en
Publication of WO2003039270A1 publication Critical patent/WO2003039270A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Child & Adolescent Psychology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Antiobestic foods and drinks containing compounds selected from the group consisting of pentacyclic triterpenes, physiologically acceptable salts thereof and derivatives of the same, in particular, antiobestic foods and drinks containing maslinic acid and/or physiologically acceptable salts thereof.
PCT/JP2002/011608 2001-11-08 2002-11-07 Antiobestic foods and drinks WO2003039270A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003541376A JPWO2003039270A1 (en) 2001-11-08 2002-11-07 Anti-obesity food and drink

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001343917 2001-11-08
JP2001-343917 2001-11-08

Publications (1)

Publication Number Publication Date
WO2003039270A1 true WO2003039270A1 (en) 2003-05-15

Family

ID=19157516

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/011608 WO2003039270A1 (en) 2001-11-08 2002-11-07 Antiobestic foods and drinks

Country Status (3)

Country Link
JP (1) JPWO2003039270A1 (en)
TW (1) TW200300069A (en)
WO (1) WO2003039270A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008508284A (en) * 2004-07-29 2008-03-21 ミシガン ステイト ユニバーシティー Methods and compositions for treating obesity, insulin related diseases, and hypercholesterolemia
WO2009121992A2 (en) 2008-04-03 2009-10-08 Biomaslinic S.L. Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of cox-2 inhibition
JP2010503644A (en) * 2006-09-18 2010-02-04 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピック Use of quinoa extract as a cosmetic and slimming agent and / or to prevent the formation of new fat in the human body
JP2010202558A (en) * 2009-03-02 2010-09-16 Nihon Univ Antiobestic agent and diabetes-ameliorating agent
JP2011236150A (en) * 2010-05-10 2011-11-24 Nippon Flour Mills Co Ltd Antiallergic agent comprising maslinic acid as active ingredient
JP2015003877A (en) * 2013-06-20 2015-01-08 国立大学法人 筑波大学 Composition comprising hydroxytyrosol or salt thereof
WO2018051471A1 (en) * 2016-09-15 2018-03-22 日本農産工業株式会社 Fat accumulation inhibitor, preadipocyte differentiation inhibitor, visceral-fat-reducing agent, and food or beverage for visceral-fat reduction

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967249A (en) * 1995-06-22 1997-03-11 Nippon Flour Mills Co Ltd Glycerophosphate dehydrogenase inhibitor
JP2000044478A (en) * 1998-07-28 2000-02-15 Pola Chem Ind Inc Acat-inhibitor and composition containing the same for preventing and curing arteriosclerosis
JP2000136130A (en) * 1998-10-30 2000-05-16 Coral Biotech Kk Suppressant for liberation of histamine
JP2001224309A (en) * 2000-02-10 2001-08-21 Nisshin Oil Mills Ltd:The Edible oil-and-fat having function to ameliorate lipid in blood
JP2001252054A (en) * 2000-01-07 2001-09-18 Kanebo Ltd Food composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967249A (en) * 1995-06-22 1997-03-11 Nippon Flour Mills Co Ltd Glycerophosphate dehydrogenase inhibitor
JP2000044478A (en) * 1998-07-28 2000-02-15 Pola Chem Ind Inc Acat-inhibitor and composition containing the same for preventing and curing arteriosclerosis
JP2000136130A (en) * 1998-10-30 2000-05-16 Coral Biotech Kk Suppressant for liberation of histamine
JP2001252054A (en) * 2000-01-07 2001-09-18 Kanebo Ltd Food composition
JP2001224309A (en) * 2000-02-10 2001-08-21 Nisshin Oil Mills Ltd:The Edible oil-and-fat having function to ameliorate lipid in blood

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008508284A (en) * 2004-07-29 2008-03-21 ミシガン ステイト ユニバーシティー Methods and compositions for treating obesity, insulin related diseases, and hypercholesterolemia
EP1771188A4 (en) * 2004-07-29 2010-04-21 Univ Michigan State METHODS AND COMPOSITIONS FOR THE TREATMENT OF OBESITY, INSULIN-ASSOCIATED DISEASES, AND HYPERCHOLESTEROLEMIA
US7772195B2 (en) * 2004-07-29 2010-08-10 Board Of Trustees Of Michigan State University Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
JP2010503644A (en) * 2006-09-18 2010-02-04 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピック Use of quinoa extract as a cosmetic and slimming agent and / or to prevent the formation of new fat in the human body
WO2009121992A2 (en) 2008-04-03 2009-10-08 Biomaslinic S.L. Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of cox-2 inhibition
JP2010202558A (en) * 2009-03-02 2010-09-16 Nihon Univ Antiobestic agent and diabetes-ameliorating agent
JP2011236150A (en) * 2010-05-10 2011-11-24 Nippon Flour Mills Co Ltd Antiallergic agent comprising maslinic acid as active ingredient
JP2015003877A (en) * 2013-06-20 2015-01-08 国立大学法人 筑波大学 Composition comprising hydroxytyrosol or salt thereof
WO2018051471A1 (en) * 2016-09-15 2018-03-22 日本農産工業株式会社 Fat accumulation inhibitor, preadipocyte differentiation inhibitor, visceral-fat-reducing agent, and food or beverage for visceral-fat reduction

Also Published As

Publication number Publication date
JPWO2003039270A1 (en) 2005-02-24
TW200300069A (en) 2003-05-16

Similar Documents

Publication Publication Date Title
WO2002043736A1 (en) Beautifying foods and drinks and peroral beautifying preparations
AU5397699A (en) Pasteurized or ultra-pasteurized complete nutritional compositions and products
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
IL211281A (en) [1,2,4]triazolo [4,3-a]pyridine derivatives and pharmaceutical compositions comprising the same
AU3696599A (en) Esterified and subsequently hydrogenated phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
AU3335300A (en) Ingredients for expanded foods
AU4549499A (en) Polyurea-based adhesives, articles therefrom, and methods of their preparation and use
EP1183954A4 (en) Fading inhibitors
AU2003259112A1 (en) Enzymatic process for the preparation of foods, feedstuffs and ingredients therefor
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
ZA200109602B (en) Purine derivatives, preparation method and pharmaceutical compositions containing same.
ZA200002610B (en) Flavor compounds.
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
WO2003039270A1 (en) Antiobestic foods and drinks
WO2000067696A3 (en) Lactic acid bacteria with anxiolytic properties and uses thereof
HK1050003A1 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them.
AU7032700A (en) Low potassium juice, method for producing thereof and food containing the same
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU7953800A (en) Drugs, drinks or foods
WO2002026717A8 (en) Hydroxy acid integrin antagonists
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
AU5483500A (en) Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
AU2001250625A1 (en) 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003541376

Country of ref document: JP

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载